Skip to main content
Log in

Cycloserine as a urinary tract antiseptic

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

A short historical review and pharmacological data indicating the suitability of cycloserine for long-term low-dose prophylaxis of urinary tract infection are presented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bailey, R. R., Roberts, A. P., Gower, P. E., de Wardener, H. E.: Prevention of urinary tract infection with low-dose nitrofurantoin.Lancet, 2, 1112 (1971).

    PubMed  Google Scholar 

  2. Birnbaum, J.: Rational design of new antibiotic combinations. In: A. G. Bearn (ed.): Antibiotics in the Management of Infections: Outlook for the 1980s. Raven Press, New York 1982, p. 81.

    Google Scholar 

  3. Bondi, A., Kornblum, J. T., Forte, C.: Inhibition of antibacterial activity of cycloserine by alpha-alanine.Proc. Soc. Exp. Biol. Med., 96, 270 (1957).

    PubMed  Google Scholar 

  4. Brumfitt, W., Cooper, J., Hamilton-Miller, J. M. T.: Prevention of recurrent urinary infections in women: a comparative trial between nitrofurantoin and methenamine hippurate.J. Urol., 126, 71 (1981).

    PubMed  Google Scholar 

  5. Bykova, M. A., Storozhev, I. A., Berezina, E. K.: On the pharmacology of D-cycloserine (in Russian).Antibiotiki, 10, 626 (1965).

    PubMed  Google Scholar 

  6. Cockett, A. T. K., Roberts, A. P., Moore, R. S., Goodwin, W. E.: Selection of antibiotics in acute pyelonephritis based on renal interstitial (lymph) concentration.Br. J. Urol., 40, 564 (1968).

    PubMed  Google Scholar 

  7. Fairbrother, R. W., Garrett, G.: Treatment of urinary infections with cycloserine.Br. Med. J., 2, 1191 (1960).

    Google Scholar 

  8. Fica, V., Matrescu, Fl., Manole, Gh.: Contributions to the study of the value of cycloserine (Tebemycin) in the treatment of acute attacks of chronic pyelonephritis (in Romanian).Rev. Med. Interna (Bucuresti),27, 291 (1975).

    Google Scholar 

  9. Georgescu, P., Savuleanu, E., Daniello, I.: The rhythm of absorption and elimination of cycloserine as studied with the chromatographic technique.Scand. J. Resp. Dis., Suppl.71, 61 (1970).

    Google Scholar 

  10. Grüneberg, R. N.: Extended treatment of urinary tract infection. In: A. W. Asscher (ed.): Management of Urinary Tract Infections. Medicine Publishing Foundation, Oxford 1980, p. 73.

    Google Scholar 

  11. Herrold, R. D.: Some considerations in the administration of novobiocin and cycloserine.J. Urol., 77, 771 (1957).

    PubMed  Google Scholar 

  12. Herrold, R. D., Boand, A. V., Kamp, M.: The treatment of stubborn urinary infections with a new antibiotic: cycloserine.Antbiot. Med., 1, 665 (1955).

    Google Scholar 

  13. Herrold, R. D., Karabatsos, N.: Prolonged administration of cycloserine in recurrent urinary infections.J. Urol., 84, 191 (1960).

    PubMed  Google Scholar 

  14. Hoeprich, P. D.: Effect of DL-alanine on D-cycloserine inhibition of bacteria.Clin. Res., 10, 111 (1962).

    Google Scholar 

  15. Hoeprich, P. D.: Alanine-cycloserine antagonism. II. Significance of phenomenon to therapy with cycloserine.Arch. Intern. Med., 112, 405 (1963).

    PubMed  Google Scholar 

  16. Hoeprich, P. D.: Alanine-cycloserine antagonism. III. Quantitative aspects and relation to heating of culture media.J. Lab. Clin. Med., 62, 657 (1963).

    PubMed  Google Scholar 

  17. Holmberg, L., Boman, G., Böttiger, L. E., Eriksson, B., Spross, R., Wessling, A.: Adverse reactions to nitrofurantoin. Analysis of 921 reports.Am. J. Med., 69, 733 (1980).

    PubMed  Google Scholar 

  18. Hughes, J., Coppridge, W. M., Roberts, L. C.: Cycloserine in chronic urinary infections.J. Urol., 80, 75 (1958).

    PubMed  Google Scholar 

  19. Janda, J.: Urovalidin Bracco in the treatment of urinary pathway infections in children (in Czech).Česk. Pediatr., 28, 445 (1973).

    Google Scholar 

  20. Kaltenis, P.: Validity of low-dose antibacterial prophylaxis of pyelonephritis in children with vesicoureteral reflux (in Russian). In: Abstracts of the 3rd All-Union Congress of Urologists. Minsk 1974, p. 163.

  21. Landes, R. R., Lyon, E. W., Burch, J. F., Davila, J. M.: Cycloserine in the treatment of acute urinary infections.J. Urol., 83, 490 (1960).

    PubMed  Google Scholar 

  22. Liwski, R., Koziolova, H., Gietko, E.: Urovalidin treatment of chronic pyelonephritis (in Polish).Pol. Arch. Med. Wewn., 43, 1181 (1969).

    PubMed  Google Scholar 

  23. Murdoch, J. McC.: Antimicrobials in 1978: a review of current opinion.Curr. Med. Res. Opin., 6, Suppl. 3, 36 (1979).

    Google Scholar 

  24. Murdoch, J. McC., Sleigh, J. D., Frazer, S. C.: Cycloserine in treatment of infection of urinary tract.Br. Med. J., 2, 1055 (1959).

    Google Scholar 

  25. Murray, B. E., Rensimer, E. R., DuPont, H. L.: Emergence of high-level trimethoprim resistance in fecalEscherichia coli during oral administration of trimethoprim or trimethoprim-sulfamethoxazole.N. Engl. J. Med., 306, 130 (1982).

    PubMed  Google Scholar 

  26. Navashin, S. M., Formina, I. P.: Rational Therapy by Antibiotics (in Russian). 4th ed. Medicina, Moscow 1982.

    Google Scholar 

  27. Ormonde, N. W. H., Gray, J. A., Murdoch, J. McC., Wallace, E., Brumfitt, W., Pursell, R., Regan, J. W.: Chronic bacteriuria due toEscherichia coli. I. Assessment of the value of combined short- and long-term treatment with cycloserine, nitrofurantoin, and sulphadimidine.J. Infect. Dis., 120, 82 (1969).

    PubMed  Google Scholar 

  28. Renzetti, A. D., Wright, K. W., Edling, J. H., Bunn, P.: Clinical, bacteriologic, and pharmacologic observations upon cycloserine.Am. Rev. Tuberc., 74, 128 (1956).

    PubMed  Google Scholar 

  29. Ronald, A. R., Harding, G. K. M., Mathias, R., Wong, C. K., Muir, P.: Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole.Can. Med. Assoc. J., 112, Spec. issue 13, 138 (1975).

    Google Scholar 

  30. Shmelev, N. A., Shabalova, L. N., Kolosovskaya, V. P.: Comparative clinico-electro-encephalographic studies on cycloserine and terizidone tolerance (in Russian).Antibiotiki, 20, 174 (1975).

    PubMed  Google Scholar 

  31. Shockman, G. D.: Reversal of cycloserine inhibition by D-alanine.Proc. Soc. Exp. Biol. Med., 101, 693 (1959).

    PubMed  Google Scholar 

  32. Spencer, J. N., Payne, H. G.: Cycloserine. Experimental studies.Antibiot. Chemother., 6, 708 (1956).

    Google Scholar 

  33. Stamey, T. A., Condy, M., Mihara, G.: Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections,N. Engl. J. Med., 296, 780 (1977).

    PubMed  Google Scholar 

  34. Stamm, W. E.: Prevention of urinary tract infections.Am. J. Med., 76, 5A, 148 (1984).

    PubMed  Google Scholar 

  35. Stamm, W. E., Counts, G. W., Wagner, K. F., Martin, D., Gregory, D., McKevitt, M., Turck, M., Holmes, K. K.: Antimicrobial prophylaxis of recurrent urinary tract infections.Ann. Intern. Med., 92, 770 (1980).

    PubMed  Google Scholar 

  36. Utkin, V. V.: Cycloserine in Therapy of Lung Tuberculosis (in Russian). Moscow 1968.

  37. Vaitilavičius, A. J., Kaltenis, P. A., Baukiené, D. K.: Intestinal microflora during long-term use of cycloserine (in Russian). In: Problems of Infectious Pathology in Lithuanian SSR. Abstr. of Conference. Vilnius 1984, p. 112.

  38. Welch, H., Putnam, L. E., Randall, W. A.: Antibactreial activity and blood and urine concentrations of cycloserine, a new antibiotic, following oral administration.Antibiot. Med., 1, 72 (1955).

    PubMed  Google Scholar 

  39. Wise, R., Andrews, J. M.: In vitro activity of fludalanine combined with pentizidone compared with those of other agents.Antimicrob. Agents Chemother., 25, 612 (1984).

    PubMed  Google Scholar 

  40. Zitkova, L., Toušek, J.: Pharmacokinetics of cycloserine and terizidone.Chemotherapy, 20, 18 (1974).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaltenis, P. Cycloserine as a urinary tract antiseptic. International Urology and Nephrology 18, 125–130 (1986). https://doi.org/10.1007/BF02082597

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02082597

Keywords

Navigation